Global radiation dose management market projected to reach $0.96 billion by 2031

DELRAY BEACH, Fla., Sept. 3, 2026 /CourierPR/ -- The global radiation dose management market is projected to reach $0.96 billion by 2031, growing at a compound annual growth rate (CAGR) of 13.3% from $0.51 billion in 2026, according to a report by MarketsandMarkets™. This forecast highlights the increasing emphasis on patient radiation safety and the need for advanced dose monitoring and management systems.

The market is driven by the rising utilization of medical imaging procedures, the adoption of automated dose management systems, and the growing emphasis on patient radiation quality assurance. Radiation dose management (RDM) systems allow organizations to collect, monitor, and report patient radiation dose and technical data, identify dose variations, and support dose optimization and quality assurance.

North America currently dominates the market, holding a 42.1% share of the global radiation dose management market in 2025. The solutions segment dominates the market, with a 69.6% share in 2025, and is expected to continue its strong growth trajectory. The cardiology segment is projected to register the highest CAGR of 14.6% during the forecast period.

The UK Health Security Agency (UKHSA) played a significant role in driving the market, publishing its fifth UK national general patient diagnostic dose survey in July 2025. This survey covered plain radiography, simple fluoroscopy, and simple interventional radiology examinations performed between 2017 and 2019, providing data from 475 radiography systems and 239 fluoroscopy systems across 169 hospitals and clinics.

In December 2025, the UKHSA also published updated National Diagnostic Reference Levels (NDRLs) covering CT, general radiography, selected fluoroscopy and interventional procedures, SPECT/PET-CT, mammography, dental X-rays, and radiotherapy imaging. These updated NDRLs provide benchmarks for healthcare organizations to establish local DRLs and support ongoing optimization of patient radiation exposure.

The services segment is expected to register high growth during the forecast period. By offering, the radiation dose management market is segmented into solutions and services. The services segment is expected to register a higher CAGR, driven by the increasing need for implementation, integration, configuration, maintenance, quality assurance, consulting, and training associated with increasingly sophisticated dose management environments.

On-premise deployment of radiation dose management solutions accounted for the largest share of the market in 2025, supported by the established deployment of RDM infrastructure within hospital and imaging facility IT environments and the need to integrate dose management systems with existing imaging and clinical information infrastructure.

Asia Pacific is projected to be the fastest-growing market during the forecast period, driven by the expansion of healthcare infrastructure, increasing adoption of CT, fluoroscopy, interventional imaging, and other radiation-based diagnostic procedures, and growing awareness of patient radiation safety. Rapid investments in hospitals and diagnostic imaging centers across China, India, Japan, South Korea, and Southeast Asian countries are increasing the installed base of advanced imaging equipment and creating greater demand for dose monitoring and optimization solutions.

Key players in the radiation dose management market include Bayer AG, GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers AG, Sectra AB, FUJIFILM Holdings Corporation, PACSHealth, LLC, Qaelum, Medsquare, Novarad, and INFINITT Healthcare Co., Ltd.

Investment and funding in the radiation dose management market are increasing, with a focus on AI-enabled imaging, cloud-based and vendor-neutral platforms, enterprise imaging software, and technologies that support dose optimization. Leading companies are expanding their capabilities through product development and strategic investments in adjacent imaging technologies. For example, GE HealthCare's planned acquisition of Intelerad strengthens its cloud-enabled enterprise imaging capabilities, while Sectra has expanded its imaging IT portfolio through the acquisition of Oxipit, an AI-based radiology company.

The market is gradually moving beyond standalone dose monitoring toward integrated, data-driven solutions that connect dose information with broader imaging and clinical workflows. The growing need to manage dose information across multiple imaging systems and support quality assurance and regulatory requirements is creating new opportunities for integrated RDM software and related services.

Mergers and acquisitions among major market participants have focused on adjacent imaging software, AI, interventional imaging, and enterprise imaging technologies. These transactions are relevant to the RDM market because they expand the imaging data, workflow, AI, and image-guided procedure capabilities that can be integrated with dose management solutions.

The total market share of the top five players is 60-70%, indicating a relatively concentrated market. This level of concentration suggests that leading vendors hold a meaningful position in the market while leaving room for other established companies and specialized RDM providers to compete.